Insights from Benchmark’s Conversation with Miles Grimshaw on the Artificial Intelligence Race

Date:

Venture firm Benchmark’s most recent addition, Miles Grimshaw, led a seed round in LangChain, a SaaS development firm that helps developers use large language models, which includes OpenAI’s model. This is in contrast to Grimshaw’s previous firm, Thrive Capital, which invested in a recent $300 million funding round for OpenAI. In an interview, Grimshaw revealed that Benchmark has five equal general partners and invests in one to two deals yearly. Despite the lure of investing in foundational model companies such as OpenAI, Benchmark has not found sufficient reason to commit funds. Instead, it focuses on the developer layer above the models and aims to be the first and most impactful partner to founders. While Grimshaw recognizes the potential of generative AI, he advised against participating in investments when model depreciation rates undermine ROI, as was seen in GPT-2 and GPT-3 models developed by OpenAI.

See also  10 Things in Tech: Twitter 2.0, Creating with AI, and Reddit Employees' Swag Warning

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.